Olanzapine Injection, Powder, For Solution
Product Images NDC 0781-3159

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0781-3159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Olanzapine 01)

Chemical structure diagram of Olanzapine, the active ingredient of the injection, powder, for solution product by Sandoz Inc. The diagram shows the molecular arrangement including nitrogen, sulfur, and carbon atoms characteristic of Olanzapine.*

FDA Label Image

Label.jpg (Olanzapine 02)

Label for Olanzapine for Injection 10 mg/vial, a sterile single-use injection powder for intramuscular use. The label includes manufacturer information for Gland Pharma Limited, India, on behalf of Sandoz Inc. It displays the NDC 0781-3159-72 and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.